1. Home
  2. UFI vs XBIT Comparison

UFI vs XBIT Comparison

Compare UFI & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unifi Inc. New

UFI

Unifi Inc. New

HOLD

Current Price

$3.85

Market Cap

74.1M

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.32

Market Cap

71.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFI
XBIT
Founded
1969
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
71.6M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
UFI
XBIT
Price
$3.85
$2.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.1K
35.6K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
57.47
N/A
EPS
N/A
N/A
Revenue
$571,344,000.00
N/A
Revenue This Year
$1.39
N/A
Revenue Next Year
$12.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.96
$2.09
52 Week High
$5.68
$3.62

Technical Indicators

Market Signals
Indicator
UFI
XBIT
Relative Strength Index (RSI) 45.15 45.58
Support Level $3.74 $2.32
Resistance Level $4.77 $2.69
Average True Range (ATR) 0.16 0.10
MACD -0.04 -0.00
Stochastic Oscillator 19.78 48.15

Price Performance

Historical Comparison
UFI
XBIT

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: